RPA1 and colonic neoplasm: Importantly, RPA1 knockdown potentiated the anti-proliferative effect of oxaliplatin in colon cancer cells, which could be ascribed to inhibition of DNA synthesis evidenced by reduced number of cells in the S phase [37].